[Economic analysis of the treatment of heart failure with beta-blockers].
作者信息
Díez-Manglano Jesús
机构信息
Servicio de Medicina Interna, Hospital Royo Villanova, Instituto Aragonés de Ciencias de la Salud, Zaragoza, España.
出版信息
Med Clin (Barc). 2013 Sep 21;141(6):265-70. doi: 10.1016/j.medcli.2013.02.011. Epub 2013 Apr 16.
PMID:23597957
Abstract
摘要
相似文献
1
[Economic analysis of the treatment of heart failure with beta-blockers].
Med Clin (Barc). 2013 Sep 21;141(6):265-70. doi: 10.1016/j.medcli.2013.02.011. Epub 2013 Apr 16.
2
[Congestive heart failure in Spain: cost-effectiveness and cost-benefit analyses of treatment with beta-blockers].
Rev Clin Esp. 2005 Apr;205(4):149-56. doi: 10.1157/13074160.
3
In heart failure, all beta-blockers are not necessarily equal.
Cleve Clin J Med. 2003 Dec;70(12):1081-7. doi: 10.3949/ccjm.70.12.1081.
4
Meta-analysis of effect of beta-blocker therapy on mortality in patients with New York Heart Association class IV chronic congestive heart failure.
Am J Cardiol. 2000 Oct 15;86(8):886-9. doi: 10.1016/s0002-9149(00)01114-0.
5
Cost-effectiveness of beta-blocker therapy with metoprolol or with carvedilol for treatment of heart failure in Canada.
Am Heart J. 2001 Sep;142(3):537-43. doi: 10.1067/mhj.2001.116479.
6
Economic impact of beta blockade in heart failure.
Am J Med. 2001 May 7;110 Suppl 7A:74S-80S. doi: 10.1016/s0002-9343(98)00387-8.
7
Nebivolol: a third-generation beta-blocker for hypertension.
Clin Ther. 2009 Mar;31(3):447-62. doi: 10.1016/j.clinthera.2009.03.007.
8
Top heart failure drugs compared.
Health News. 2003 Sep;9(9):6-7.
9
The impact of beta-blockade on mortality rates in patients with congestive heart failure.
J Card Fail. 2000 Jun;6(2 Suppl 1):15-24.
10
A cost-effectiveness analysis of bisoprolol for heart failure.
Eur J Heart Fail. 2001 Jun;3(3):365-71. doi: 10.1016/s1388-9842(01)00132-5.
Zotero 插件